June 3, 2022
Not intended for U.S. and UK Media – The 2022 American Diabetes Association’s 82nd Scientific Sessions:
Bayer to present new Kerendia™ (finerenone) data from comprehensive clinical trial program across a broad range of patients with chronic kidney disease and type 2 diabetes
